We pioneered the potential implications of epidermal growth factor in the context of lung inflammation, as well as potential correlates with other widely used studies in clinical medicine, and the ability of this molecule to behave as a predictor of severity in the context of COVID‐19, with a view to obtaining real‐world data that will help understand the implications of this molecule in the development of the lung environment. Here, EGF is linked to COVID-19.